Ngā hua rapu - Mahak Fatima

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer

    Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer mā Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani

    I whakaputaina 2022-11-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis

    Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis mā Prashant Kesharwani, Mahak Fatima, Vanshikha Singh, Afsana Sheikh, Waleed H. Almalki, Virendra Gajbhiye, Amirhossein Sahebkar

    I whakaputaina 2022-11-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells

    Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells mā Mahak Fatima, Muhammad Mubashar Iqbal Ahmed, Faiza Batool, Anjum Riaz, Moazzam Ali, Birgitte Munch-Petersen, Zeeshan Mutahir

    I whakaputaina 2019-11-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Gold nanoparticles and gold nanorods in the landscape of cancer therapy

    Gold nanoparticles and gold nanorods in the landscape of cancer therapy mā Prashant Kesharwani, Ruiyang Ma, Liang Sang, Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab, Neelima Gupta, Zhe-Sheng Chen, Yun Zhou

    I whakaputaina 2023-06-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management

    In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management mā Mahak Fatima, Sadia Monawwar, Sradhanjali Mohapatra, Thomson Santosh Alex, Abdulrahman Ahmed, Mohamad Taleuzzaman, Asgar Ali, Mohammad Javed Ansari, Mohd. Aamir Mirza, Zeenat Iqbal

    I whakaputaina 2021-11-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells

    The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells mā Ivana Samaržija, Ivana Samaržija, Vasyl Lukiyanchuk, Marija Lončarić, Anja Rac-Justament, Nikolina Stojanović, Ielizaveta Gorodetska, Uğur Kahya, Uğur Kahya, Jonathan D. Humphries, Mahak Fatima, Martin J. Humphries, Ana Fröbe, Anna Dubrovska, Anna Dubrovska, Anna Dubrovska, Anna Dubrovska, Anna Dubrovska, Andreja Ambriović-Ristov

    I whakaputaina 2024-08-01
    Whiwhi kuputuhi katoa
    Tuhinga
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: